Yesterday I had the opportunity to present NurExone Biologic‘s technology at the ILANIT/FISEB Conference, during a session called “Latest advances in extracellular vesicles: from bench to bedside”.
It is amazing to see the growing interest in EVs both in academia an in the Biomed Industry, and this year for the first time the Israel Society for extracellular vesicles (#ISREV) was an official included society at the conference, with an individual session dedicated to EVs.